spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  MRgFUS 

 HSMN NewsFeed - 4 Mar 2024
Insightec's Groundbreaking Transcranial MR-Guided Focused Ultrasound (MRgFUS) Approved for Additional Reimbursement for Essential Tremor in Germany
Devices Neurology Reimbursement
 HSMN NewsFeed - 25 Feb 2019
INSIGHTEC Announces Expansion of Positive Insurance Coverage for MR-guided Focused Ultrasound to Treat Essential Tremor
Devices Neurosurgery Reimbursement
 HSMN NewsFeed - 31 Jan 2018
INSIGHTEC Closes $150 Million Series E Financing
Devices Venture Capital
 HSMN NewsFeed - 27 Nov 2017
FDA Approves First Study of INSIGHTEC's Exablate Neuro to Open the Blood-Brain Barrier in Glioblastoma Patients
Devices Oncology FDA
 HSMN NewsFeed - 25 Aug 2016
Pivotal Study Results Published in New England Journal of Medicine (NEJM) Confirm Safety and Efficacy of INSIGHTEC's Exablate Neuro System for the Treatment of Essential Tremor
Devices Neurology
 HSMN NewsFeed - 15 Aug 2016
Siemens and INSIGHTEC Sign Agreement to Expand Access to Exablate Neuro Technology
Devices Neurology Radiology
 HSMN NewsFeed - 27 Jul 2016
Coverage of INSIGHTEC's Exablate for Pain Palliation of Bone Metastases Expands to 99.8 Million Members in the US
Devices Oncology Reimbursement
 HSMN NewsFeed - 8 Jan 2016
INSIGHTEC Announces Changes in Leadership and Appoints a New General Manager
Devices Personnel
 HSMN NewsFeed - 22 Oct 2015
INSIGHTEC Submits Pre-Market Application (PMA) for FDA Approval of Exablate Neuro for Treatment of Essential Tremor
Devices Neurology Neurosurgery FDA
 HSMN NewsFeed - 7 Oct 2015
FDA Approves INSIGHTEC's Next Generation Exablate Fibroid Treatment System and Removes Requirement for Patients to be Family Complete
Devices FDA
 HSMN NewsFeed - 30 Jun 2014
InSightec Announces a New Series D Funding of $50 Million to Accelerate Market Development of MR-Guided Focused Ultrasound Noninvasive Treatments
Devices Venture Capital
 HSMN NewsFeed - 29 Jul 2013
ExAblate Receives Approval of Chinese Food and Drug Administration
Devices Regulatory
 HSMN NewsFeed - 4 Dec 2012
InSightec's ExAblate Neuro System Awarded European CE Mark for Non-invasive Treatment of Neurological Disorders in the Brain
Devices Neurology Regulatory
 HSMN NewsFeed - 4 Dec 2012
Elbit Imaging Ltd. Announces InSightec's ExAblate Neuro System Awarded European CE Mark for Non-invasive Treatment of Neurological Disorders in the Brain
Devices Neurology Regulatory
 HSMN NewsFeed - 26 Nov 2012
GE Healthcare Redefines Comfort, Confidence and Connectivity in Radiology at RSNA Conference
Devices Radiology
 HSMN NewsFeed - 5 Nov 2012
iCAD Reports Significantly Improved Medicare Payment for Intraoperative Radiation Therapy
Devices Oncology Reimbursement
 HSMN NewsFeed - 22 Oct 2012
FDA Approves New Non-Invasive, Non-Ionizing Radiation Therapy to Treat Pain from Bone Metastases
Devices Oncology FDA
 HSMN NewsFeed - 3 Jan 2012
Enrollment in First MRgFUS Essential Tremor Feasibility Trial Completed
Devices Neurosurgery
 HSMN NewsFeed - 21 Sep 2011
ExAblate(R) Neuro has Been Used to treat 30 Patients with Chronic Neurological Disorders Such as Essential Tremor, Neuropathic Pain and Parkinson's Disease
Devices Neurology
 HSMN NewsFeed - 29 Sep 2010
InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010
Devices Surgery
 HSMN NewsFeed - 13 Jan 2010
First Non-Invasive Technology for Treatment of Uterine Fibroids Awarded MHLW Approval in Japan
Devices Regulatory
 HSMN NewsFeed - 14 Jul 2009
A Swiss Team Uses Transcranial MR-Guided Focused Ultrasound to Treat Patients With Functional Brain Disorders
Devices Neurosurgery
 HSMN NewsFeed - 7 Apr 2009
FDA Approves Label Change for Non-Invasive Fibroid Treatment
Devices FDA
 HSMN NewsFeed - 21 Jul 2008
First U.S. Patient Undergoes Non-Invasive Magnetic Resonance-Guided Focused Ultrasound Procedure to Relieve Pain From Bone Metastases
Devices Oncology
 HSMN NewsFeed - 6 Jun 2007
InSightec Receives European CE Mark for ExAblate(R) 2000 Treatment of Pain Caused by Bone Metastases
Devices Regulatory Oncology
 HSMN NewsFeed - 14 May 2007
InSightec Encourages Uterine Fibroid Sufferers to Ask Their Doctors About Less Invasive Treatment Options
Devices
 HSMN NewsFeed - 9 May 2007
Enhanced MR-Guided Focused Ultrasound (MRgFUS) Guidelines Demonstrate Improved Efficacy and Durability for the Treatment of Uterine Fibroids
Devices
 HSMN NewsFeed - 12 Mar 2007
InSightec's ExAblate(R) 2000 Magnetic Resonance-Guided Focused Ultrasound (MRgFUS) System is Approved for Sale in Canada
Devices Regulatory
 HSMN NewsFeed - 5 Mar 2007
Elbit Medical Group Announces FDA Approval of New Version of InSightec's ExAblate(R) 2000 That Speeds Up Treatment Time and the Use of ExAblate 2000 System With GE Healthcare's 3 Tesla Magnetic Resonance Imaging System
Devices FDA
 HSMN NewsFeed - 1 Mar 2007
FDA Approves use of InSightec's ExAblate(R) 2000 With GE Healthcare's 3 Tesla Magnetic Resonance Imaging System
Devices FDA
 HSMN NewsFeed - 1 Mar 2007
FDA Approves New Version of InSightec's ExAblate(R) 2000 That Speeds up Treatment Time
Devices FDA
 HSMN NewsFeed - 31 May 2006
First North American Patient Undergoes MR Guided Focused Ultrasound Surgery to Ease Pain From Bone Metastases
Devices Surgery
Return to NewsFeed  

 Additional items found! 3

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 3 additional stories matching:
MRgFUS
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.